These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 27109900)

  • 41. Emergency contraception: which is the best?
    Mittal S
    Minerva Ginecol; 2016 Dec; 68(6):687-99. PubMed ID: 27082029
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Emergency Contraception.
    Batur P; Kransdorf LN; Casey PM
    Mayo Clin Proc; 2016 Jun; 91(6):802-7. PubMed ID: 27261868
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Emergency Contraception: Do Your Patients Have a Plan B?
    Bullock H; Salcedo J
    Obstet Gynecol Clin North Am; 2015 Dec; 42(4):699-712. PubMed ID: 26598310
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ulipristal acetate: review of the efficacy and safety of a newly approved agent for emergency contraception.
    Richardson AR; Maltz FN
    Clin Ther; 2012 Jan; 34(1):24-36. PubMed ID: 22154199
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Levonorgestrel vs. Copper Intrauterine Devices for Emergency Contraception.
    Turok DK; Gero A; Simmons RG; Kaiser JE; Stoddard GJ; Sexsmith CD; Gawron LM; Sanders JN
    N Engl J Med; 2021 Jan; 384(4):335-344. PubMed ID: 33503342
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The end of IUD marketing in the United States: what does it mean for American women?].
    Forrest JD
    Contracept Fertil Sex (Paris); 1987 Mar; 15(3):291-300. PubMed ID: 12341479
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of Knowledge of Self-removability of Intrauterine Contraceptives on Uptake, Continuation, and Satisfaction.
    Raifman S; Barar R; Foster D
    Womens Health Issues; 2018; 28(1):68-74. PubMed ID: 28882549
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Update on emergency contraception.
    Fok WK; Blumenthal PD
    Curr Opin Obstet Gynecol; 2016 Dec; 28(6):522-529. PubMed ID: 27676405
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A prospective, randomized, pharmacodynamic study of quick-starting a desogestrel progestin-only pill following ulipristal acetate for emergency contraception.
    Brache V; Cochon L; Duijkers IJ; Levy DP; Kapp N; Monteil C; Abitbol JL; Klipping C
    Hum Reprod; 2015 Dec; 30(12):2785-93. PubMed ID: 26405263
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: the European Active Surveillance Study for Intrauterine Devices.
    Heinemann K; Reed S; Moehner S; Minh TD
    Contraception; 2015 Apr; 91(4):280-3. PubMed ID: 25601350
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of copper intrauterine device with levonorgestrel-bearing intrauterine system for post-abortion contraception.
    Bilgehan F; Dilbaz B; Karadag B; Deveci CD
    J Obstet Gynaecol Res; 2015 Sep; 41(9):1426-32. PubMed ID: 26180028
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effects on ovarian activity of ulipristal acetate when 'quickstarting' a combined oral contraceptive pill: a prospective, randomized, double-blind parallel-arm, placebo-controlled study.
    Cameron ST; Berger C; Michie L; Klipping C; Gemzell-Danielsson K
    Hum Reprod; 2015 Jul; 30(7):1566-72. PubMed ID: 25994664
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Beyond Plan B: A Qualitative Study of Canadian Pharmacists' Emergency Contraception Counselling Practices.
    Wong K; Hum S; McCarthy L; Dunn S
    J Obstet Gynaecol Can; 2017 Nov; 39(11):1021-1027. PubMed ID: 28757409
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Six-month and 1-year continuation rates following postpartum insertion of implants and intrauterine devices.
    Woo I; Seifert S; Hendricks D; Jamshidi RM; Burke AE; Fox MC
    Contraception; 2015 Dec; 92(6):532-5. PubMed ID: 26408376
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis.
    Glasier AF; Cameron ST; Fine PM; Logan SJ; Casale W; Van Horn J; Sogor L; Blithe DL; Scherrer B; Mathe H; Jaspart A; Ulmann A; Gainer E
    Lancet; 2010 Feb; 375(9714):555-62. PubMed ID: 20116841
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intrauterine contraception after medical abortion: factors affecting success of early insertion.
    Pohjoranta E; Suhonen S; Mentula M; Heikinheimo O
    Contraception; 2017 Mar; 95(3):257-262. PubMed ID: 27836586
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term utilization and continuation of intrauterine devices.
    Diedrich JT; Madden T; Zhao Q; Peipert JF
    Am J Obstet Gynecol; 2015 Dec; 213(6):822.e1-6. PubMed ID: 26409157
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Emergency contraception.
    Dunn S; Guilbert É;
    J Obstet Gynaecol Can; 2012 Sep; 34(9):870-878. PubMed ID: 22971457
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevention of unintended pregnancies by using emergency contraception: the differences between levonorgestrel and ulipristal acetate. A theoretical model using data from a survey on the use of emergency contraception in Spain, 2017.
    Lete I; Doval JL; Pérez-Campos E; Alonso MJ; Sellers G; Sánchez-Borrego R
    Gynecol Endocrinol; 2019 Jul; 35(7):582-585. PubMed ID: 30614295
    [No Abstract]   [Full Text] [Related]  

  • 60. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
    Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
    Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.